Effective with dates of service on and after October 1, 2018, and in accordance with Empire’s Pharmacy and Therapeutic (P&T) process, Empire will update its drug lists that support Commercial health plans.

 

Please note, this update does not apply to the Select Drug List and does not impact Medicaid and Medicare plans.

To ensure a smooth transition and minimize member costs, providers should review these changes and consider prescribing a drug on formulary or on a lower tier, if appropriate.

 

View a summary of changes here.

 



Featured In:
August 2018 Empire Provider Newsletter